Truist Securities’s $250 target on DGX

DGX Quest Diagnostics

$228 → $250 (+10%) by Jul 2027

Hold · raises · said Jul 24, 2026 · 12-month default horizon

Open: judged on the close on Jul 24, 2027

The article this target came from

Truist raises Quest Diagnostics stock price target on strong results

Investing.com · Jul 24, 2026

Truist Securities raised its price target on Quest Diagnostics shares ([NYSE:DGX](https://www.investing.com/equities/quest-diag)) to $250 from $225 on Thursday while maintaining a Hold rating.

Truist Securities’s track record → Quest Diagnostics →

A fact about what Truist Securities published, as reported by Investing.com, not a recommendation from Dalsna Finance; Truist Securities is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.